The Spain neurology devices market size reached USD 0.23 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 0.42 Billion by 2033, exhibiting a growth rate (CAGR) of 6.77% during 2025-2033. Spain’s neurology devices market is driven by rising healthcare investments, increasing neurological disorders, and advancements in treatment technologies. Moreover, government support for neurotechnology research, expanding private funding for startups, and demand for non-invasive diagnostic tools are key trends driving market expansion.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 0.23 Billion |
Market Forecast in 2033 | USD 0.42 Billion |
Market Growth Rate (2025-2033) | 6.77% |
Advancing Neurological Treatments with Innovative Devices
Spain’s neurology devices market is experiencing significant advancements driven by increasing investments in research, cutting-edge technologies, and a growing focus on minimally invasive treatments. The demand for advanced neurological treatments has surged due to the rising incidence of strokes, neurodegenerative diseases, and an aging population. Medical technology companies are focusing on innovation to enhance treatment precision and improve patient outcomes. The integration of AI, robotics, and catheter-based procedures is transforming neurological care, offering more efficient solutions for complex conditions. In July 2024, Anaconda Biomed received IDE approval for its ATHENA study on the ANA Funnel Catheter, marking a major milestone in stroke treatment research. This development strengthens Spain’s reputation in medical technology by supporting the advancement of thrombectomy devices. With this approval, Anaconda Biomed is set to conduct clinical trials to evaluate the catheter’s effectiveness, potentially offering a safer and more efficient alternative for stroke patients. The IDE approval also attracts global attention to Spain’s role in neurological innovation, encouraging further investments in research and development. Also, the collaboration between medical institutions and technology companies to develop next-generation neurology devices. AI-powered diagnostics, brain implants, and neurostimulation therapies are emerging as game changers, enabling early disease detection and targeted treatments.
Rising Investments in Neurology Startups
Growing investments in neurotechnology startups are driving Spain’s neurology devices market by accelerating the development of advanced brain-monitoring and treatment solutions. Funding enables innovation, supporting new therapies for neurological disorders like Parkinson’s and epilepsy, boosting market expansion. Inbrain Neuroelectronics, a Barcelona-based company, raised €46 Million in 2024 to develop graphene-based neural implants. These implants aim to improve treatments for neurological disorders like Parkinson’s disease and epilepsy by enhancing brain signal modulation. This investment signals growing interest in advanced neurology solutions. The Spanish government is also fostering growth through initiatives such as the planned National Center for Neurotechnology, which bring together over 250 researchers to develop next-generation brain-monitoring and treatment devices. This project highlights Spain’s strategic push to become a key player in the neurotechnology sector. Furthermore, Spain’s neurology devices sector is set to grow, with both private and public funding accelerating innovation, thereby offering improved solutions for neurological disorders while strengthening the country’s position in medical technology.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region/country level for 2025-2033. Our report has categorized the market based on product and end user.
Product Insights:
The report has provided a detailed breakup and analysis of the market based on the product. This includes neurostimulation devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid management devices, and others.
End User Insights:
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This hospitals, ambulatory surgery centers, and neurology clinics.
Region Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Northern Spain, Eastern Spain, Southern Spain, and Central Spain.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Products Covered | Neurostimulation Devices, Neurosurgery Devices, Interventional Neurology Devices, Cerebrospinal Fluid Management Devices, Others |
End Users Covered | Hospitals, Ambulatory Surgery Centers, Neurology Clinics |
Regions Covered | Northern Spain, Eastern Spain, Southern Spain, Central Spain |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: